Increasing contribution of non-alcoholic fatty liver disease to hepatocellular carcinoma incidence and mortality in U.S. Medicare

Ítems similars

• Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
  per: Wong, Carrie R, et al.
  Publicat: (2016)
• Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD): Trends, Mortality, and Socioeconomic Disparities in the U.S., 1998–2020
  per: Paul Wasuwanich, et al.
  Publicat: (2025-01-01)
• Increased plasma corticosterone contributes to the development of alcoholic fatty liver in mice
  per: Sun, Xiuhua, et al.
  Publicat: (2013)
• Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern
  per: Dhamija, Ekta, et al.
  Publicat: (2019)
• Hepatocellular Carcinoma in the Absence of Cirrhosis in US Veterans is Associated with Non-Alcoholic Fatty Liver Disease
  per: Mittal, Sahil, et al.
  Publicat: (2015)